Showing results (21-30 of 313) with videos related to

Sort By:
Pageof 32
Clinical Advances in Hematology & Oncology : H&O|March 14, 2015
Advances in the treatment of relapsed/refractory acute lymphoblastic leukemia: a case study compendiumGail J Roboz, Elias J Jabbour, Stefan Faderl, et al.
Reviews in Clinical and Experimental Hematology|August 28, 2002
Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectivesStefan Faderl, Guillermo Garcia-Manero, Deborah A Thomas, et al.
Leukemia & Lymphoma|September 14, 2007
Clofarabine: past, present, and futureHagop M Kantarjian, Sima Jeha, Varsha Gandhi, et al.
Expert Review of Hematology|November 19, 2010
Clofarabine in leukemiaHady Ghanem, Elias Jabbour, Stefan Faderl, et al.
Anticancer Research|September 15, 2005
WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML)Stefan Faderl, Alessandra Ferrajoli, David Harris, et al.
Leukemia Research|July 11, 2006
Atiprimod blocks phosphorylation of JAK-STAT and inhibits proliferation of acute myeloid leukemia (AML) cellsStefan Faderl, Alessandra Ferrajoli, David Harris, et al.
Leukemia Research|January 23, 2003
N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL)Stefan Faderl, Reuben Lotan, Hagop M Kantarjian, et al.
Cancer|March 13, 2010
Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrenceStefan Faderl, Alessandra Ferrajoli, William Wierda, et al.
Leukemia Research|August 4, 2009
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 YearsStefan Faderl, William Wierda, Susan O'Brien, et al.
Blood|March 29, 2003
Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemiaStefan Faderl, David Harris, Quin Van, et al.
Pageof 32